Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the republic of Congo

被引:98
|
作者
Formenty, P [1 ]
Leroy, EM
Epelboin, A
Libama, F
Lenzi, M
Sudeck, H
Yaba, P
Allarangar, Y
Boumandouki, P
Nkounkou, VB
Drosten, C
Grolla, A
Feldmann, H
Roth, C
机构
[1] WHO, Global Alert & Response Team, Dept Communicable Dis Surveillance & Response, 20 Ave Appia, CH-1211 Geneva 27, Switzerland
[2] CNRS, Paris, France
[3] Museum Natl Hist Nat, F-75231 Paris, France
[4] Bernhard Nocht Inst Trop Med, Hamburg, Germany
[5] Ctr Int Rech Med Franceville, Inst Rech Dev, U034, Franceville, Gabon
[6] WHO, Reg Off, Libreville, Gabon
[7] Minist Sante & Populat, Brazzaville, Rep Congo
[8] Publ Hlth Agcy Canada, Special Pathogens Program, Natl Microbiol Lab, Winnipeg, MB, Canada
关键词
D O I
10.1086/503836
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Patients who have refused to provide blood samples has meant that there have been significant delays in confirming outbreaks of Ebola virus hemorrhagic fever (EVHF). During the 2 EVHF outbreaks in the Republic of Congo in 2003, we assessed the use of oral fluid specimens versus serum samples for laboratory confirmation of cases of EVHF. Methods. Serum and oral fluid specimens were obtained from 24 patients with suspected Ebola and 10 healthy control subjects. Specimens were analyzed for immunoglobulin G antibodies by enzyme-linked immunosorbent assay (ELISA) and for Ebola virus by antigen detection ELISA and reverse-transcriptase polymerase chain reaction (RT-PCR). Oral fluid specimens were collected with a commercially available collection device. Results. We failed to detect antibodies against Ebola in the oral fluid specimens obtained from patients whose serum samples were seropositive. All patients with positive serum RT-PCR results also had positive results for their oral fluid specimens. Conclusions. This study demonstrates the usefulness of oral fluid samples for the investigation of Ebola outbreaks, but further development in antibodies and antigen detection in oral fluid specimens is needed before these samples are used for filovirus surveillance activities in Africa.
引用
收藏
页码:1521 / 1526
页数:6
相关论文
共 50 条
  • [21] A PROBABLE CASE OF EBOLA VIRUS HEMORRHAGIC-FEVER IN KENYA
    TEEPE, RGC
    JOHNSON, BK
    OCHENG, D
    GICHOGO, A
    LANGATT, A
    NGINDU, A
    KILEY, M
    JOHNSON, KM
    MCCORMICK, JB
    EAST AFRICAN MEDICAL JOURNAL, 1983, 60 (10) : 718 - 722
  • [22] Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995
    Guimard, Y
    Bwaka, MA
    Colebunders, R
    Calain, P
    Massamba, M
    De Roo, A
    Mupapa, KD
    Kibadi, K
    Kuvula, KJ
    Ndaberey, DE
    Katwiki, KR
    Mapanda, BB
    Nkuku, OB
    Fleerackers, Y
    Van den Enden, E
    Kipasa, MA
    JOURNAL OF INFECTIOUS DISEASES, 1999, 179 : S268 - S273
  • [23] Unrecognized Ebola hemorrhagic fever at Mosango Hospital during the 1995 epidemic in Kikwit, Democratic Republic of the Congo
    Bonnet, MJ
    Akamituna, P
    Mazaya, A
    EMERGING INFECTIOUS DISEASES, 1998, 4 (03) : 508 - 510
  • [24] Detection of Vaccine-Induced Antibodies to Ebola Virus in Oral Fluid
    Lambe, Teresa
    Rampling, Tommy
    Samuel, Dhan
    Bowyer, Georgina
    Ewer, Katie J.
    Venkatraman, Navin
    Edmans, Matthew
    Dicks, Steve
    Hill, Adrian V. S.
    Tedder, Richard S.
    Gilbert, Sarah C.
    OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (01):
  • [25] Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: Clinical observations in 103 patients
    Bwaka, MA
    Bonnet, MJ
    Calain, P
    Colebunders, R
    De Roo, A
    Guimard, Y
    Katwiki, KR
    Kibadi, K
    Kipasa, MA
    Kuvula, KJ
    Mapanda, BB
    Massamba, M
    Mupapa, KD
    Muyembe-Tamfum, JJ
    Ndaberey, E
    Peters, CJ
    Rollin, PE
    Van den Enden, E
    JOURNAL OF INFECTIOUS DISEASES, 1999, 179 : S1 - S7
  • [26] Isolated case of Ebola hemorrhagic fever with mucormycosis complications, Kinshasa, Democratic Republic of the Congo
    Kalongi, Y
    Mwanza, K
    Tshisuaka, M
    Lusiama, N
    Ntando, E
    Kanzake, L
    Shieh, WJ
    Zaki, SR
    Lloyd, ES
    Ksiazek, TG
    Rollin, PE
    JOURNAL OF INFECTIOUS DISEASES, 1999, 179 : S15 - S17
  • [27] Antibody Use during an Outbreak of Ebola Virus Disease in the Democratic Republic of Congo, 2020
    Mulangu, Sabue
    Mbala-Kingebeni, Placide
    Mbaya, Olivier T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (12): : 1188 - 1191
  • [28] Effect of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Vaccination on Ebola Virus Disease Illness and Death, Democratic Republic of the Congo
    Rupani, Neil
    Ngole, Mbong Eta
    Lee, J. Austin
    Aluisio, Adam R.
    Gainey, Monique
    Perera, Shiromi M.
    Ntamwinja, Lina Kashibura
    Matafali, Ruffin Mbusa
    Muhayangabo, Rigo Fraterne
    Makoyi, Fiston Nganga
    Laghari, Razia
    Levine, Adam C.
    Kearney, Alexis S.
    EMERGING INFECTIOUS DISEASES, 2022, 28 (06) : 1180 - 1188
  • [29] Ebola virus disease in DR Congo
    Zwizwai, Ruth
    LANCET INFECTIOUS DISEASES, 2020, 20 (09): : 1019 - 1019
  • [30] Crisis of Ebola virus disease in Democratic Republic of the Congo, A call to action
    Hangi, Samson
    Balagizi, Fabien
    Biamba, Chrispin
    Banga, Styves
    Elembwe, Hardy
    Cakwira, Hugues
    Bisimwa, Jospin
    Sironge, Leonard
    Bhattacharjee, Priyadarshini
    Akilimali, Aymar
    NEW MICROBES AND NEW INFECTIONS, 2024, 60-61